DNAVEC CORPORATION Trademark

Trademark Overview


On Tuesday, November 12, 2013, a trademark application was filed for DNAVEC CORPORATION with the United States Patent and Trademark Office. The USPTO has given the DNAVEC CORPORATION trademark a serial number of 79140680. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, April 7, 2016. This trademark is owned by DNAVEC CORPORATION. The DNAVEC CORPORATION trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Chemical reagents not for medical or veterinary purposes; protein in raw material form for scientific and medical research; enzymes for scientific and medical research; biochemicals, namely, polypeptides for in vitro and in vivo scientific and research use; biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research use; chemical reagents comprising antibodies not for medical or veterinary purposes; chemical agents for chelating and sequestering; higher fatty acids for use in the field of scientific research, reagents, cosmetics, and pharmaceuticals

Anti-cancer preparations; anti-sarcoma preparations; contrasting agent for X-ray imaging; diagnostic reagents for medical purposes; radio-isotope markers for therapeutic or diagnostic use; veterinary preparations for veterinary vaccines; biological preparations for the treatment of cancer, critical limb ischemia, cystic fibrosis, retinitis pigmentosa, AIDs, influenza, and Alzheimer's disease; preparations for gene therapy, namely, introducing genes to human and animal cells, tissues, organs and living bodies, and cell growth media for medical purposes; vaccines; gene vaccines; RNA vectors for introducing genes to human and animal cells, tissues, organs and living bodies, and cell growth media for medical use, namely, for gene therapy

Testing, inspection, research, or development of pharmaceuticals, cosmetics, or foodstuff; testing, inspection, research, or development of pharmaceutical preparations for gene therapy; testing, inspection, research, or development of vaccines; testing, inspection, research, or development of recombinant proteins; medical, chemical, biochemical, biological and bacteriological research and functional analysis of genes or proteins; testing, inspection, or research related to technologies for manufacturing genetically engineered animals, plants, and vectors; testing, inspection, research, or development of vector technologies, namely, medical and scientific research in the field of genetics and genetic engineering; testing, inspection, or research on agriculture, livestock breeding, or fisheries; testing, inspection, research, or development of chemicals for life science; testing or research on machines and instruments; computer software design, computer programming, or maintenance of com...
dnavec corporation

General Information


Serial Number79140680
Word MarkDNAVEC CORPORATION
Filing DateTuesday, November 12, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, April 7, 2016
Registration Number4680265
Registration DateTuesday, February 3, 2015
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 18, 2014

Trademark Statements


Indication of Colors claimedThe color(s) black, blue, and white is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"CORPORATION"
Description of MarkThe mark consists of a black rectangle containing a smaller blue rectangle in the upper left corner and a white circle and semi-circle in the upper right corner all to the left of the black stylized text "DNAVEC CORPORATION".
Goods and ServicesChemical reagents not for medical or veterinary purposes; protein in raw material form for scientific and medical research; enzymes for scientific and medical research; biochemicals, namely, polypeptides for in vitro and in vivo scientific and research use; biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research use; chemical reagents comprising antibodies not for medical or veterinary purposes; chemical agents for chelating and sequestering; higher fatty acids for use in the field of scientific research, reagents, cosmetics, and pharmaceuticals
Goods and ServicesAnti-cancer preparations; anti-sarcoma preparations; contrasting agent for X-ray imaging; diagnostic reagents for medical purposes; radio-isotope markers for therapeutic or diagnostic use; veterinary preparations for veterinary vaccines; biological preparations for the treatment of cancer, critical limb ischemia, cystic fibrosis, retinitis pigmentosa, AIDs, influenza, and Alzheimer's disease; preparations for gene therapy, namely, introducing genes to human and animal cells, tissues, organs and living bodies, and cell growth media for medical purposes; vaccines; gene vaccines; RNA vectors for introducing genes to human and animal cells, tissues, organs and living bodies, and cell growth media for medical use, namely, for gene therapy
Goods and ServicesTesting, inspection, research, or development of pharmaceuticals, cosmetics, or foodstuff; testing, inspection, research, or development of pharmaceutical preparations for gene therapy; testing, inspection, research, or development of vaccines; testing, inspection, research, or development of recombinant proteins; medical, chemical, biochemical, biological and bacteriological research and functional analysis of genes or proteins; testing, inspection, or research related to technologies for manufacturing genetically engineered animals, plants, and vectors; testing, inspection, research, or development of vector technologies, namely, medical and scientific research in the field of genetics and genetic engineering; testing, inspection, or research on agriculture, livestock breeding, or fisheries; testing, inspection, research, or development of chemicals for life science; testing or research on machines and instruments; computer software design, computer programming, or maintenance of computer software; rental of computers and rental of computer programs

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, April 7, 2016
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, April 7, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, April 7, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameID Pharma Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameDNAVEC CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIbaraki 300-2611
JP

Party NameDNAVEC CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIbaraki 300-2611
JP

Trademark Events


Event DateEvent Description
Friday, November 4, 2016NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, November 4, 2016DEATH OF INTERNATIONAL REGISTRATION
Thursday, October 1, 2015CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, July 11, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, June 12, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, June 4, 2015FINAL DISPOSITION NOTICE SENT TO IB
Thursday, June 4, 2015FINAL DISPOSITION PROCESSED
Sunday, May 3, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 3, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, November 18, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 18, 2014PUBLISHED FOR OPPOSITION
Friday, November 14, 2014NOTIFICATION PROCESSED BY IB
Wednesday, October 29, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 29, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 29, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 14, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 1, 2014ASSIGNED TO LIE
Friday, September 19, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 9, 2014EXAMINER'S AMENDMENT ENTERED
Tuesday, September 9, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 9, 2014EXAMINERS AMENDMENT E-MAILED
Tuesday, September 9, 2014EXAMINERS AMENDMENT -WRITTEN
Friday, August 29, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 29, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 29, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 18, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 28, 2014REFUSAL PROCESSED BY IB
Thursday, March 6, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, March 6, 2014REFUSAL PROCESSED BY MPU
Thursday, March 6, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, March 5, 2014NON-FINAL ACTION WRITTEN
Thursday, February 27, 2014ASSIGNED TO EXAMINER
Saturday, January 4, 2014APPLICATION FILING RECEIPT MAILED
Tuesday, December 31, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 30, 2013LIMITATION FROM ORIGINAL APPLICATION ENTERED
Saturday, December 28, 2013SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB